http://www.mynewsdesk.com/pressroom/cavidi Mynewsdesk RSS - Press Releases, News, and Blog Posts. http://www.mynewsdesk.com/pressroom/cavidi http://www.mynewsdesk.com/images/redesign/graphics/logos/logo-small.png 128 23 en 15 Tue, 14 May 2013 10:43:54 +0200 Cavidi and PartnerTech join forces to scale up Global delivery of novel HIV diagnostic technology. http://www.mynewsdesk.com/pressroom/cavidi/pressrelease/view/partnertech-and-cavidi-develop-unique-instrument-for-hiv-test-865469?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/pressrelease/view/partnertech-and-cavidi-develop-unique-instrument-for-hiv-test-865469?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Tue, 30 Apr 2013 15:37:00 +0200 http://www.mynewsdesk.com/pressroom/cavidi/news/view/swedish-ministry-of-health-presents-swecare-export-award-2012-58589?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/swedish-ministry-of-health-presents-swecare-export-award-2012-58589?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Thu, 25 Apr 2013 19:31:00 +0200 The Swecare Export Award is to encourage and highlight successful Swedish companies and create good examples of successful export ventures. The aim is to reward creativity and innovation and promote new successful models for internationalization in all areas of Swedish health care. The award is given in conjunction with the annual Swecare meeting in Stockholm. http://www.mynewsdesk.com/pressroom/cavidi/pressrelease/view/cavidi-wins-swecare-export-award-2012-860017?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/pressrelease/view/cavidi-wins-swecare-export-award-2012-860017?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Tue, 12 Feb 2013 21:56:28 +0100 Lusaka, Zambia. H.E. First Lady Dr. Christine Kaseba meets with Fabio Baglioni, Cavidi VP Global Sales & Marketing (center) and Regional Manager for Africa, Dr. Walter Campos (left). Cavidi joined a Swedish healthcare delegation with SWECARE in Zambia last week. The delegation visited Lusaka for roundtable discussions with the Zambian MOH sharing healthcare innovation and ideas. http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-in-zambia-53963?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-in-zambia-53963?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Thu, 29 Nov 2012 17:13:00 +0100 This past year has brought more good news in the battle against HIV/AIDS with UNAIDS stating, “On the cusp of the fourth decade of the AIDS epidemic, the world has turned the corner—it has halted and begun to reverse the spread of HIV.” UNAID’s 2012 report cited 700,000 fewer new HIV infections in 2011 than in 2001. AIDS-related deaths have been reduced by one-third in the past six years. http://www.mynewsdesk.com/pressroom/cavidi/pressrelease/view/time-for-a-new-gold-standard-in-hiv-viral-load-monitoring-817780?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/pressrelease/view/time-for-a-new-gold-standard-in-hiv-viral-load-monitoring-817780?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Wed, 17 Oct 2012 11:23:00 +0200 Amazing strides have been made in providing access to Antiretroviral Therapy (ART) in resource-limited settings. In 2011, around 8 million HIV-infected patients living in low- and middle-income countries have access to ART compared to just 400,000 a decade ago. http://www.mynewsdesk.com/pressroom/cavidi/pressrelease/view/hiv-viral-load-monitoring-from-patient-to-public-health-issue-804154?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/pressrelease/view/hiv-viral-load-monitoring-from-patient-to-public-health-issue-804154?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Mon, 23 Jul 2012 12:30:00 +0200 There are around 370,000 new infant infections worldwide each year. A significant number of these children will die if they are not diagnosed early and started on antiretroviral drugs (ARVs). The problem is not the lack of ARVs as much as a lack of proper HIV early infant diagnostics (EID). Recent reports indicate that RT-technology may be an answer to improved access to (EID). http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/could-rt-technology-help-close-the-eid-gap-13842?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/could-rt-technology-help-close-the-eid-gap-13842?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Wed, 20 Jun 2012 15:35:00 +0200 A celebration at Cavidi today marked 25 years since the first patent application for a novel RT technology. This technology made HIV viral load testing more accessible allowing doctors to know when to start, stop and switch HIV medications. Version 3 of the test launched in 2008 and is well proven in HIV clinics in the most challenging markets of the world. http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-celebrates-25-year-mark-42315?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-celebrates-25-year-mark-42315?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Sun, 03 Jun 2012 13:59:00 +0200 http://www.mynewsdesk.com/pressroom/cavidi/news/view/reception-honoring-prof-john-mills-41363?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/reception-honoring-prof-john-mills-41363?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Thu, 19 Apr 2012 13:04:00 +0200 How innovations originating from low-income countries may provide solutions that can help in developed countries. http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/commentary-on-reverse-innovation-12159?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/commentary-on-reverse-innovation-12159?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Mon, 16 Apr 2012 13:52:00 +0200 http://www.mynewsdesk.com/pressroom/cavidi/news/view/three-new-talents-join-the-cavidi-team-38730?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/three-new-talents-join-the-cavidi-team-38730?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Wed, 29 Feb 2012 17:24:00 +0100 http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-moves-to-new-production-and-r-d-facilities-42339?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-moves-to-new-production-and-r-d-facilities-42339?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Wed, 29 Feb 2012 17:24:00 +0100 Cavidi has moved to a new facility in Uppsala due to a rapid increase in market demand for their ExaVir Load HIV drug monitoring product. The facility is built to suit Cavidi's needs for multiple new R&D projects and production scale up. "The flexible, modular design of the space allows for unlimited future expansion and was the key to site selection" said CEO John Reisky de Dubnic. http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-moves-to-new-production-and-r-d-facilities-42338?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-moves-to-new-production-and-r-d-facilities-42338?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Wed, 29 Feb 2012 16:08:00 +0100 http://www.mynewsdesk.com/pressroom/cavidi/news/view/swedish-heath-care-delegation-visit-to-india-36661?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/swedish-heath-care-delegation-visit-to-india-36661?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Thu, 01 Dec 2011 14:56:00 +0100 Observations on the role of innovation in the battle against HIV/AIDS http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/getting-to-zero-will-require-more-than-funding-to-succeed-11325?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/getting-to-zero-will-require-more-than-funding-to-succeed-11325?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Thu, 13 Oct 2011 10:52:00 +0200 Although the North American and Western European experience has historically been with HIV-1 group M subtype B virus, this is changing rapidly as migrants and refugees from developing countries with non-B subtype infections now present for care in the developed world, and travelers to developing countries acquire non-B subtype infection abroad and present for care at home. http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/the-hiv-subtype-picture-11344?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/the-hiv-subtype-picture-11344?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Thu, 15 Sep 2011 10:07:00 +0200 Measuring an individual’s HIV viral load provides healthcare professionals with an accurate picture of viral activity. This is a powerful tool in fighting the HIV pandemic for three reasons: http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/three-reasons-hiv-viral-load-monitoring-matters-11382?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/blog_post/view/three-reasons-hiv-viral-load-monitoring-matters-11382?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Mon, 20 Jun 2011 15:54:00 +0200 http://www.mynewsdesk.com/pressroom/cavidi/news/view/honorable-recognition-of-cavidi-scientific-advisor-36657?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/honorable-recognition-of-cavidi-scientific-advisor-36657?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Tue, 09 Nov 2010 16:03:00 +0100 With affordable, effective diagnostic testing, Cavidi is helping physicians provide essential treatment to HIV patients in resource-strapped developing countries. http://www.mynewsdesk.com/pressroom/cavidi/news/view/helping-hiv-patients-get-the-best-possible-treatment-36658?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/helping-hiv-patients-get-the-best-possible-treatment-36658?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB Sun, 18 Jul 2010 11:00:00 +0200 http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-brings-its-message-to-aids-2010-in-vienna-38268?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news http://www.mynewsdesk.com/pressroom/cavidi/news/view/cavidi-brings-its-message-to-aids-2010-in-vienna-38268?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Cavidi AB